Bellevue Medtech & Services B Cap

Reference Data

ISIN LU0415391431
Valor Number 3882623
Bloomberg Global ID BBG000PM9VX9
Fund Name Bellevue Medtech & Services B Cap
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies.
Peculiarities

Fund Prices

Current Price * 725.49 EUR 02.04.2025
Previous Price * 725.35 EUR 01.04.2025
52 Week High * 807.88 EUR 05.02.2025
52 Week Low * 658.85 EUR 05.08.2024
NAV * 725.49 EUR 02.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,517,126,299
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance -1.41% 31.12.2024
02.04.2025
YTD Performance (in CHF) +0.20% 31.12.2024
02.04.2025
1 month -7.97% 03.03.2025
02.04.2025
3 months -1.97% 02.01.2025
02.04.2025
6 months +2.06% 02.10.2024
02.04.2025
1 year +4.04% 02.04.2024
02.04.2025
2 years +15.66% 03.04.2023
02.04.2025
3 years +4.37% 04.04.2022
02.04.2025
5 years +58.33% 02.04.2020
02.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Abbott Laboratories 10.16%
Boston Scientific Corp 10.00%
Stryker Corp 9.83%
Intuitive Surgical Inc 9.37%
Essilorluxottica 5.09%
Medtronic PLC 5.00%
Becton Dickinson & Co 4.48%
Alcon Inc 3.74%
Edwards Lifesciences Corp 3.43%
DexCom Inc 3.18%
Last data update 28.02.2025

Cost / Risk

TER 2.23%
TER date 01.02.2021
Performance Fee ***
PTR
Max. Management Fee *** 1.60%
Ongoing Charges *** 2.15%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)